Figure 3.—Rear Admiral James M. Flint, U.S. Navy surgeon and first honorary curator of the Section of Materia Medica. (Photo courtesy of the Library of Congress.)
The Section commenced with a wealth of material. After the close of the 1876 centennial exhibition, its materia medica collection had been stored with the other collections in a warehouse, awaiting an appropriation by Congress for transfer and installation. This collection was gradually brought into the new National Museum after that building’s completion in 1881. Many other materia medica specimens were transferred from the Department of Agriculture. In addition to these large collections of crude drugs, generous contributions came from several prominent pharmaceutical firms such as Parke, Davis & Company of Detroit, Michigan; Wallace Brothers of Statesville, North Carolina; and Schieffelin and Company of New York City. These manufacturing houses are mentioned here because they and their agents abroad were the first to take interest and donate to the Section, complete assortments of contemporary remedial agents then in common use throughout the United States and Europe, besides many hundreds of “rare and curious drugs.” Thus, in spite of difficulties encountered from bringing several collections into the building at one time, the materia medica exhibition got off to a good start.
It was Dr. Flint, the first curator, who stated in 1883 that remedial agents used by a nation or a community are as indicative of the degree of their cultural development and standard of living as is the nature of their food, the character of their dwellings, and their social and religious traditions. Therefore, he felt that collections of drugs and medical, surgical and pharmaceutical instruments and appliances should not be thought of or designed as instructive to the specialist only, but should also possess a general interest for the public. Because of these objectives, Dr. Flint added, this section was conceived as a departmental division for the collecting and exhibiting of objects related to medicine, surgery, pharmacology, hygiene, and all material related to the health field at large. [4]
During his first term of curatorship (1881-1884), Dr. Flint devoted much of his time to sorting, examining, identifying, and classifying the materia medica specimens. [5] In 1881, he issued a memorandum of instructions to be followed by collectors of drugs and urged them to give detailed and accurate information regarding acquired specimens so that they might be “more than mere museum curiosities.” In addition, in 1883, he prepared a brief manual of classification of the materia medica collection in the Museum as well as a useful, detailed catalog of informational labels of the individual objects on exhibition. The unpublished catalog is still the property of the Smithsonian Institution Archives, Division of Medical Sciences’ Library.
It was Dr. Flint’s ambition to obtain a comprehensive, worldwide collection of all substances used as remedies. Then, in order to identify drugs from foreign countries, he tried to collect illustrated works on medical botany and printed pharmacopoeias of all nations having them. He rightly defined an official pharmacopoeia as “a book containing directions for the identification and preparation of medicines prepared and issued with the sanction of a government or organized and authorized medical and pharmaceutical societies. Its purpose is to establish uniformity in the nomenclature of remedies and in the character and potency of the pharmaceutical preparations. It is enacted by legislation, and thus becomes binding on all who prepare drugs or sell them for medication.” By soliciting the help of various American consuls and Navy officers abroad, about 16 such official pharmacopoeias were collected, making an almost complete international representation of all available, official, drug standards. With these sources of information, Dr. Flint compiled and arranged an international list of materia medica specimens, indicating the authorized preparations of each. By so doing, the first curator of this Section took the initiative at least in proposing and, to some extent acting, on the preparation of an international pharmacopoeia of drugs used in existing authorized formularies giving “official synonyms, and tables showing the constituents and comparative strength of all preparations.” [6] This undertaking is of special importance in the history of American pharmacy, since it was probably the first attempt of its kind in the United States.[7] In addition, colored plates and photographs of medicinal plants were collected, forming the nucleus of the Division’s current collection of pictorial and photographic material related to the history of the health field.
Dr. Flint also put on exhibition 630 Chinese materia medica specimens from the 1876 Philadelphia centennial. These had been collected originally by the Chinese Imperial Customs Commission for the centennial and were subsequently given to this country.
In 1881, the numbered objects in the Section’s register amounted to 1,574 entries. In the following year, 1,590 more specimens were added, most of them drugs in their crude state. By the end of 1883, the total collection had reached 4,037, out of which 3,240 individual drugs in good condition were classified and put on display. Of these, about 500 specimens with beautiful illustrations of parts of their original plants had been mounted for exhibition. The drug exhibitions also included materials transferred from the Department of Agriculture in 1881, which originally had been brought from Central America and South America for the 1876 centennial exhibition, a variety of opium specimens from Turkey, and a number of rare drugs listed in the official formulary which were acquired from the Museum of Karachi in what was then India.